Legacy Pharmaceutical Packaging LLC recalls Losartan Potassium Tablets, USP, 100 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716,
Legacy Pharmaceutical Packaging LLC recalls Losartan Potassium Tablets, 100mg, 30-count bottles due to detected impurity NMBA. This may pose health risks. Check NDC codes and distribution dates for affected products.
Recall notice
CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) detected
Contact the company & request your remedy
What happened, in plain English
Legacy Pharmaceutical Packaging LLC is recalling Losartan Potassium Tablets, 100 mg, 30-count bottles because they contain an impurity called N-Methylnitrosobutyric acid (NMBA). This impurity could potentially cause health risks, so affected consumers should stop using the product. Read more at govinfonow.com/recall/39134-legacy-pharmaceutical-losartan-tablets-recall-impurity-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39134-legacy-pharmaceutical-losartan-tablets-recall-impurity-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1050-2019
Cite this page
“Legacy Pharmaceutical Losartan Tablets Recall: Impurity Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39134-legacy-pharmaceutical-losartan-tablets-recall-impurity-risk. Based on FDA recall #D-1050-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1050-2019%22&limit=1).
Why it’s dangerous
The tablets contain an impurity called N-Methylnitrosobutyric acid (NMBA) that was detected during manufacturing. This impurity may pose health risks, though the specific risks are not clearly described in the recall notice.
Who’s affected
People who have the recalled Losartan Potassium Tablets, 100 mg, 30-count bottles from Wal-Mart stores in Bentonville, AR. Those with hypertension who require this medication are most at risk.
How to tell if you have this one
Check for Losartan Potassium Tablets, 100 mg, 30-count bottles with NDC codes listed in the recall notice. The products were distributed by Wal-Mart in Bentonville, AR starting from November 2019 through June 2020.
- Brand
Legacy Pharmaceutical Packaging LLC- Category
Drug
All 3 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Ongoing- Distribution
Wal-Mart distribution centers in AR, CA, GA, IN and MD
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1048-2019 | Losartan Potassium Tablets, USP, 25 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045 NDC 68645-577-54; Lots: 180952, exp Oct-19, 180953, exp Dec-19, 181086, exp Sep-19, 181572, exp Jan-20 | 456,732 bottles |
| D-1049-2019 | Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045. NDC 68645-578-54; Lots: 180921, exp Sep-19, 180922, exp Oct-19, 180923, 180924, 181118, exp Nov-19, 181119, exp Oct-19, 181407, exp Nov-19, 181408, exp Dec-19, 181573, 181725, 181726, exp Feb-20, 181948, exp Mar-20, 181960, exp Feb-20, 182385, 182386, 182387, exp Mar-20 | 2,851,284 bottles |
| D-1050-2019 | Losartan Potassium Tablets, USP, 100 mg, 30 tablet bottles, Rx Only, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ 08854, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045. NDC 68645-579-54; 180886, Nov-19; 180887, 180888, 180905, Dec-19; 181123, Sep-2019; 181124, Oct-2019, 181125, Aug-19, 181351, Nov-19, 181352, Dec-19, 181551, Nov-19, 181628, 181629, 181727, 181728, Jun-20; 181890, Mar-20; 181891, 181897, Jun-20; 182114, Mar-20; 182119, 182120, Jun-20 | 2,497,856 bottles |
What to do — step by step
Stop Using Product
Discard the recalled Losartan Potassium Tablets, 100 mg, 30-count bottles immediately.
Questions people ask
What is the impurity in the recalled tablets?
The recall mentions N-Methylnitrosobutyric acid (NMBA) was detected, but does not specify health risks.
How can I check if I have the recalled product?
Check the NDC codes listed in the recall notice (e.g., 68645-579-54) and distribution dates from November 2019 through June 2020.
Do I need to contact a doctor?
The recall does not specify that medical consultation is required.
Contact Legacy Pharmaceutical Packaging LLC
We’ve drafted a message you can send Legacy Pharmaceutical Packaging LLC to request your refund or repair — edit it as you like.
Subject: Recall D-1050-2019 — Legacy Pharmaceutical Packaging LLC Legacy Pharmaceutical Packaging LLC Hello, I own a Legacy Pharmaceutical Packaging LLC that is covered by recall D-1050-2019 from Legacy Pharmaceutical Packaging LLC. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1050-2019 (March 1, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1050-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.